Regulatory & Legal

Kairos Power begins construction on its Hermes 2 plant, the first power-producing Gen IV reactor in the US, promising a new era of clean, affordable energy.

A new gene therapy that reprograms cancer cells into immune activators shows major promise, blending personalized treatment with off-the-shelf convenience.

A new tokenized offering bundles 100 IP-based companies, pioneering an industrialized approach to innovation finance amid growing regulatory clarity.

The amended $12M deal introduces a milestone-linked warrant and sets the stage for AIxCrypto to tokenize Faraday Future's stock, bridging EVs and Web3.

A new joint venture will build four advanced hybrid tugs for Woodside's massive LNG terminal, signaling a major investment in sustainable maritime tech.

Varvara Development Group raises C$15M to fund its cyanide-free gold mine in Romania, as major shareholder Eldorado Gold increases its stake to 19.9%.

MLB legend Darryl Strawberry shares his recovery journey, highlighting Gaudenzia's fight against addiction amidst a regional public health crisis.

While national reading scores falter, a Mississippi school sees 63% of its most challenged readers make gains. Here's how they are doing it.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

New guidelines advise biennial screening for women 50-74 and caution for others, a move that has drawn sharp criticism from other medical bodies.

Six years after Hurricane Laura, Lake Charles opens a world-class Mardi Gras museum, signaling a new era of cultural tourism and resilience.

Vaxart's new $25M financing deal provides a crucial cash runway, but is it a savvy strategic move or a necessary step to stay in the race?

Dr. Jennifer Shuford, a crisis-tested leader from Texas, is named CDC Deputy Director, a move experts hope will stabilize the beleaguered agency.

Health groups blast federal inaction as tens of thousands of teens start vaping, demanding an immediate national ban on the flavoured products fueling the crisis.

With global regulatory approvals secured, Gilead extends its tender offer for Arcellx, moving closer to acquiring a potential best-in-class CAR T therapy.

With $16M in new funding and landmark trial results, ScreenPoint Medical is poised to redefine breast cancer screening with its powerful AI technology.

Canada's first Indigenous Governor General will deliver a keynote at the UN, highlighting reconciliation and the link between rights and health.

Theo is opening its gold-backed, yield-bearing stablecoin globally after it held steady through market chaos, aiming to attract $1 billion by year-end.

Kizik, known for its step-in lifestyle shoes, is betting its patented hands-free tech can compete in the performance running market. Is it a game-changer?

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.